COVID-19 Early Treatment Fund

The COVID-19 Early Treatment Fund is on a mission to find an existing drug or drug combination that, when given early, reduces hospitalization and fatality rates by 75% or more. CETF-sponsored randomized outpatient trial shows that early treatment with fluvoxamine can dramatically reduce hospitalization rates by 75% or more. For more information visit here.